about
Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infectionCD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjectsCD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllersLoss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cellsDe novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infectionEpigenetic regulation of telomerase expression in HIV-1-specific CD8+ T cells.Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllersConsistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infectionLILRB2 interaction with HLA class I correlates with control of HIV-1 infection.Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypesPotent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers.Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infectionProlonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like PropertiesPreferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China.Human immunodeficiency virus type 1 specific cytotoxic T lymphocyte responses in Chinese infected with HIV-1 B'/C Recombinant (CRF07_BC)A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cellsTCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infectionStructural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressorsHIV-1 persistence in CD4+ T cells with stem cell-like properties.Unravelling the mechanisms of durable control of HIV-1.Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells.Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth.Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection.Inter-clade cross-reactivity of HIV-1-specific T cell responses in human immunodeficiency virus type 1 infection in China.Identification of HLA-A11-restricted HIV-1-specific cytotoxic T-lymphocyte epitopes in China.Association between HIV Type 1-specific T cell responses and CD4+ T cell counts or CD4+:CD8+ T cell ratios in HIV Type 1 subtype B infection in China.Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors.Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.Random T-cell receptor recruitment in human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells from genetically identical twins infected with the same HIV-1 strain.HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity.Relative dominance of Env-gp41-specific cytotoxic T lymphocytes responses in HIV-1 advanced infection.HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.Differences in the expressed HLA class I alleles effect the differential clustering of HIV type 1-specific T cell responses in infected Chinese and caucasians.A Reproducibility-Based Computational Framework Identifies an Inducible, Enhanced Antiviral State in Dendritic Cells from HIV-1 Elite Controllers.
P50
Q24564623-37A5FFA5-38ED-42A7-B451-783F0CFA64EEQ24798701-3E7BEE75-29F6-42F3-AB46-FAECC4E7FC67Q28307312-E4130CDE-1ED3-4CDF-BE2A-632772F105D7Q33262230-0A85F5AF-42DB-48DD-8058-DA0226A40B7BQ33724305-52D65A37-5EFD-4881-9CC1-B9F83F3DCD04Q33811660-90A03DEF-F60F-4C8F-A0E5-9754A8000C0DQ33981572-80A310D0-ECCD-4AF7-AD8C-506AC759E269Q34045616-480C88D8-AF84-42A4-A65C-4B6D19AAD31AQ34074877-7E6E6761-2928-48C2-9E17-74E2AC040D5AQ34120046-60CDC378-9DF4-44F3-989C-962963177CD1Q34361731-68D554CC-9C0D-4B37-896A-81F139C2D900Q35112707-5F3F855B-6AD2-4753-83DB-007ADF0809A2Q35149407-8DC1688B-EAC8-4186-BD6E-96F55181BD59Q35635344-0106A991-1ACE-47D2-836C-9EE1CD195AC0Q35661586-348CCE4A-5FE0-486B-A2B0-520B5AC5E157Q35785225-47249FC3-10F8-453C-9AF7-04B458D31542Q35861157-92B6B364-5AD8-4698-9128-C3A0BAE48B0FQ35932357-0CA505D2-000C-422A-9732-3ECE2BB7891EQ36059759-73F762D5-2DBB-4180-814E-DDDA1B95C2FEQ36229149-14E4096E-B9A9-4149-9BD8-5369B9B8F7C8Q36513955-147851E3-51A7-4650-9A6B-5A8B1173C04FQ36673297-1A2348AE-4A83-4D31-AF13-633080756153Q36948586-B337753E-609C-4A0B-BABE-8E47D0BED72FQ37646541-A20A8BC0-E9A5-475C-9B1F-2E0CAA44358AQ38116710-142AA9AF-0850-4E05-9F01-47D9571CF12CQ38719409-3059406C-8061-48D5-BCA5-70DF77E8D46BQ38990744-6192F995-3EC7-4D47-84BD-7B20D14EB664Q39737687-523B0DFE-0614-4A6D-89BE-90B65DB7E0D6Q40235980-0C31F3AF-5FAC-4D9A-8EC2-4D507A4E038AQ40246806-3CC92FC3-5750-4346-9F31-6D4861348613Q40297613-03312E92-FD79-4F9E-AD09-D99C7E098E36Q40615883-7FC130F7-7E91-4BF5-9B46-1EB3A43184B4Q40661591-3918C8D5-266B-4013-AD32-3AFC5AAA25AAQ41858955-58F5FB91-5295-4A51-994E-82466F05A4CCQ43438499-C4A8F3B8-6089-49E3-BC81-E20738D56605Q43785613-3815A6C6-1B9D-433A-894E-BB49D5CD9811Q45729968-8CD9F4D6-724A-419F-B405-45B585EF410FQ47309381-21BB7985-E309-4B2A-BFFE-012E8257169CQ47373214-77104DCB-55FC-4FBD-8AAA-BFC1AA6AC1B1Q47548194-A7A722C3-8DD8-4D38-A1E9-423785D10C54
P50
name
Xu G Yu
@en
type
label
Xu G Yu
@en
prefLabel
Xu G Yu
@en